Evidence map›Paper›PMID 38111608›Full record

ArticleFrontiers in digital health2023

Prospective clinical validation of the Empatica EmbracePlus wristband as a reflective pulse oximeter.

Giulia Gerboni, Giulia Comunale, Weixuan Chen, Jessie Lever Taylor, Matteo Migliorini, Rosalind Picard, Marisa Cruz, Giulia Regalia

Open access · goldAbstract read
In one paragraph

Article in Frontiers in digital health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. LOTUS Software to Process Wearable EmbracePlus Data.Sensors (Basel, Switzerland) · 2024
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Giulia Gerboni *Empatica, Inc., Cambridge, MA, United States.
Giulia Comunale *Empatica, Inc., Cambridge, MA, United States.
Weixuan ChenEmpatica, Inc., Cambridge, MA, United States.
Jessie Lever TaylorEmpatica, Inc., Cambridge, MA, United States.
Matteo MiglioriniEmpatica, Inc., Cambridge, MA, United States.
Rosalind PicardEmpatica, Inc., Cambridge, MA, United States.
Marisa CruzEmpatica, Inc., Cambridge, MA, United States.
Giulia RegaliaEmpatica, Inc., Cambridge, MA, United States.
Massachusetts Institute of Technology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Respiratory diseases such as chronic obstructive pulmonary disease, obstructive sleep apnea syndrome, and COVID-19 may cause a decrease in arterial oxygen saturation (SaO Methods: Healthy adult participants were recruited in a controlled desaturation protocol to reproduce mild, moderate, and severe hypoxic conditions with SaO Results: The controlled hypoxia study yielded 373 conclusive measurements on 15 subjects, including 30% of participants with dark skin pigmentation (V-VI on the Fitzpatrick scale). The accuracy root mean square ( Discussion: This study demonstrates that the EmbracePlus wristband could be used to assess SpO

Indexed as

blood oxygen saturationFDA clearancereflective pulse oximeterrespiratory diseasewearable devicewrist photoplethysmography

Identifiers

PMID38111608
PMCPMC10726006
OpenAlexW4389326790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.